XML 17 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
OPERATING ACTIVITIES    
Net income (loss) $ 1,253,729 $ (931,636)
Adjustments to reconcile net income (loss) to net cash provided by operating activities (245,108) 1,852,625
Net Cash Provided By Operating Activities 1,008,621 920,989
INVESTING ACTIVITIES    
Proceeds from sales, maturities, calls and prepayments of fixed maturity securities 993,834 370,028
Cost of fixed maturity securities purchased (1,771,986) (889,888)
Proceeds from sales of equity securities 138,702 146,116
Cost of equity securities purchased (293,322) (209,576)
Net change in short-term investments 675,339 (256,698)
Cost of other investments purchased (83,490) (18,251)
Additions to property and equipment (79,443) (110,544)
Consolidation of Markel CATCo Re, net 0 629,955
Distributions to Markel CATCo Re noncontrolling interests for buy-out transaction 0 (169,380)
Proceeds from sales of subsidiaries, net 41,302 109,505
Other 5,503 (4,628)
Net Cash Used By Investing Activities (373,561) (403,361)
FINANCING ACTIVITIES    
Additions to senior long-term debt and other debt 356,085 529,051
Repayment of senior long-term debt and other debt (646,264) (387,165)
Advance funding for repayment of senior long-term debt 0 350,000
Repurchases of common stock (187,161) (126,291)
Dividends paid on preferred stock (18,000) (18,000)
Redemption of Markel CATCo Re noncontrolling interests (88,997) 0
Purchase of noncontrolling interests (21,665) 7,492
Other (23,879) (41,796)
Net Cash Used By Financing Activities (629,881) (386,709)
Effect of foreign currency rate changes on cash, cash equivalents, restricted cash and restricted cash equivalents 14,237 (100,549)
Increase in cash, cash equivalents, restricted cash and restricted cash equivalents 19,416 30,370
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period 5,221,513 4,880,947
CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS AT END OF PERIOD $ 5,240,929 $ 4,911,317